Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Meet the Regents: Jadyn Fisher
- Congratulations ASU, NAU, and UA Fall graduates!!
- The PBC is Proud to Join the Arizona Venture Alliance!
- Why bioscience and healthcare innovators are looking to Phoenix
- ASU on the cusp of becoming a $1B research university
- ASU launches groundbreaking partnership to address water insecurity in Arizona
- TGen-ASU Study Reveals Lasting Effects Of Common Herbicide On Brain Health